Expression of E-Cadherin/β-Catenin, PTEN-PI3K-/Akt and P53 in Low Grade and High Grade Serous Ovarian Carcinoma

被引:0
|
作者
Wang, G. [1 ]
Chen, S. [1 ]
Yuan, F. [1 ]
Lin, Z. [1 ]
Chen, G. [2 ]
Wu, Q. [3 ]
机构
[1] Cent South Univ, Affiliated Haikou Hosp, Haikou, Hainan, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Dept Radiat & Med Oncol,Hubei Key Lab Tumor Biol, Wuhan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2625
引用
收藏
页码:E280 / E280
页数:1
相关论文
共 50 条
  • [21] DETECTION AND CHARACTERIZATION OF P53 PRIONS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Heinzl, N.
    Maritschnegg, E.
    Koziel, K.
    Horvat, R.
    Sehouli, J.
    Braicu, I.
    Vergote, I.
    van Nieuwenhuysen, E.
    Mahner, S.
    Obermayr, E.
    Schuster, E.
    Holzer, B.
    Concin, N.
    Zeillinger, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1521 - 1521
  • [22] DETECTION AND CHARACTERIZATION OF P53 PRIONS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Heinzl, N.
    Maritschnegg, E.
    Koziel, K.
    Horvat, R.
    Sehouli, J.
    Braicu, I.
    Vergote, I.
    van Nieuwenhuysen, E.
    Mahner, S.
    Obermayr, E.
    Schuster, E.
    Holzer, B.
    Concin, N.
    Zeillinger, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 298 - 298
  • [23] CORRELATION OF E-CADHERIN AND P-CADHERIN EXPRESSION WITH DIFFERENTIATION GRADE AND MODE OF INVASION IN GINGIVAL CARCINOMA
    SAKAKI, T
    WATO, M
    KAJI, R
    MUSHIMOTO, K
    SHIRASU, R
    TANAKA, A
    [J]. PATHOLOGY INTERNATIONAL, 1994, 44 (04) : 280 - 286
  • [24] Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma
    Kang, Hyo Jeong
    Chun, Sung-Min
    Kim, Kyu-Rae
    Sohn, Insuk
    Sung, Chang Ohk
    [J]. PLOS ONE, 2013, 8 (08):
  • [25] A Study of Ovarian High Grade Serous Carcinoma with IHC p53 Positive and Negative Patterns by Targeted NGS
    Zomorrodian, S.
    Fallon, J. T.
    Han, L.
    Dimitrova, N.
    Zhuge, J.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1038 - 1038
  • [26] Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy
    Cierniak, S.
    Koktysz, R.
    Jesiotr, M.
    Gasowska-Bodnar, A.
    Bodnar, L.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (05) : 744 - 751
  • [27] THE EXPRESSION OF THE PI3K/AKT/mTOR PATHWAY AS A PROGNOSTIC FACTOR IN PATIENTS WITH ADVANCED HIGH GRADE SEROUS OVARIAN CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Cierniak, S.
    Koktysz, R.
    Jesiotr, M.
    Gasowska-Bodnar, A.
    Kozlowski, W.
    Bodnar, L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 126 - 126
  • [28] Angiogenesis, cyclooxygenase-2 and p53 expression in borderline, low grade and high grade ovarian epithelial neoplasms
    Pansare, V
    Ali-Fehmi, R
    Lawerence, WD
    Morris, R
    Munkarah, AR
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 204A - 204A
  • [29] Angiogenesis, cyclooxygenase-2 and p53 expression in borderline, low grade and high grade ovarian epithelial neoplasms
    Pansare, V
    Ali-Fehmi, R
    Lawerence, W
    Morris, R
    Munkarah, AR
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 204A - 204A
  • [30] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 639 - 640